EGR1 and head and neck squamous cell carcinoma: Oxytocin has been demonstrated to increase Egr-1 expression via an EGFR- and ERK-dependent pathway in head and neck squamous cell carcinoma, which may inhibit tumor invasion and metastasis by promoting E-cadherin overexpression [86].